Technical CommentsInfectious Disease

Response to Comment on “A small-molecule antivirulence agent for treating Clostridium difficile infection”

See allHide authors and affiliations

Science Translational Medicine  21 Dec 2016:
Vol. 8, Issue 370, pp. 370tr2
DOI: 10.1126/scitranslmed.aaf3410

Article Information

vol. 8 no. 370 370tr2

DOI: 
https://doi.org/10.1126/scitranslmed.aaf3410
PubMed: 
28003551
Published By: 
American Association for the Advancement of Science
Print ISSN: 
1946-6234
Online ISSN: 
1946-6242
History: 
  • Received for publication January 28, 2016
  • Accepted for publication December 6, 2016
  • .
Copyright & Usage: 
Copyright © 2016, American Association for the Advancement of Science

Author Information

  1. Kristina Oresic Bender,
  2. Megan Garland and
  3. Matthew Bogyo*
  1. Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.
  1. ↵*Corresponding author. Email: mbogyo{at}stanford.edu

Altmetric

Article usage

Article usage: December 2016 to January 2021

AbstractFullPdf
Dec 20162955254142
Jan 201790110982
Feb 20171144622
Mar 20171494420
Apr 2017862529
May 2017441719
Jun 201735219
Jul 201728813
Aug 2017431313
Sep 2017801717
Oct 20171261513
Nov 2017981321
Dec 2017731822
Jan 2018651111
Feb 20185637
Mar 2018641811
Apr 2018391412
May 2018441512
Jun 2018401910
Jul 201828177
Aug 20182284
Sep 20182445
Oct 201856915
Nov 201835610
Dec 20182343
Jan 20193348
Feb 20197467
Mar 20191463
Apr 201925912
May 201972815
Jun 20194115
Jul 201912210
Aug 20190136
Sep 20192145
Oct 201952316
Nov 20193307
Dec 20195134
Jan 20203247
Feb 20204184
Mar 202042010
Apr 20202202
May 20201123
Jun 20201116
Jul 20202135
Aug 2020353
Sep 2020191
Oct 20201157
Nov 20202139
Dec 20202163
Jan 2021237

View Full Text

Article Tools

  • Email
  • Print

  • Alerts
  • Citation tools

  • Response to Comment on “A small-molecule antivirulence agent for treating Clostridium difficile infection”

    By Kristina Oresic Bender, Megan Garland, Matthew Bogyo

    Science Translational Medicine : 370tr2

    Ebselen’s antivirulence activity in Clostridium difficile infection is likely due to multiple modes of action, but the contribution of each to its efficacy remains unclear.

    CiteULike logo Connotea logo del.icio.us logo Digg logo Facebook logo Google logo Mendeley logo Reddit logo Twitter logo

My saved folders

Stay Connected to Science Translational Medicine

Related Content

Similar Articles in:

Citing Articles in:

Navigate This Article